<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0074027-Coelmont1">
 <label>37</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Coelmont</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Paeshuyse</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Windisch</surname>
   <given-names>MP</given-names>
  </name>, 
  <name>
   <surname>De</surname>
   <given-names>CE</given-names>
  </name>, 
  <name>
   <surname>Bartenschlager</surname>
   <given-names>R</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2006</year>) 
  <article-title>Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2′-C-methylcytidine, the active component of valopicitabine</article-title>. 
  <source>Antimicrob Agents Chemother 50</source>
  <volume>3444–3446</volume>: 
  <fpage>50/10/3444</fpage>
  <comment>doi:
   <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.00372-06" xmlns:xlink="http://www.w3.org/1999/xlink">10.1128/AAC.00372-06</ext-link>
  </comment>
 </mixed-citation>
</ref>
